相关实验视频
Updated: Jul 8, 2025

07:44
Evaluation of Synapse Density in Hippocampal Rodent Brain Slices
Published on: October 6, 2017
17.2K
突触密度通过网络功能障碍影响临床严重性,而突触密度与前叶退行相关的综合征则通过网络功能障碍影响临床严重性
David J Whiteside1,2, Negin Holland3,4, Kamen A Tsvetanov5
1Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. djw216@cam.ac.uk.
Nature communications
|December 19, 2023
概括
前叶退化导致显著的突触损失,影响大脑网络功能和临床严重程度. 这项研究强调了突触密度和连接性变化如何影响FTLD患者的行为.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 放射化学 放射化学是指辐射化学.
背景情况:
- 前叶退化 (FTLD) 具有广泛的突触损失的特征.
- 了解突触损失对网络功能的影响对于开发治疗策略至关重要.
- 之前的研究已经确定了FTLD中的突触损失,但其网络后果需要进一步调查.
研究的目的:
- 研究突触密度,神经元分散和FTLD中的网络功能之间的关系.
- 确定这些因素与FTLD综合征的临床严重程度的相关性.
主要方法:
- 招募了55名患有FTLD综合征的参与者和24名健康对照.
- 使用[11C]UCB-J正子发射断层扫描 (PET) 测量突触密度,准SV2A.
- 通过扩散磁共振成像 (dMRI) 评估神经元分散,通过静止状态功能性MRI (rs-fMRI) 评估网络功能.
主要成果:
- 突触密度和神经元分散与功能连接性降低有关,独立于大脑缩.
- 功能连接性显著缓解了突触密度和临床严重性之间的关系.
- 这些发现表明,突触损失,网络功能的改变和FTLD中的行为结果之间存在明显的联系.
结论:
- 突触损失是FTLD综合征的关键病理特征,对大脑网络功能有重大影响.
- 功能连接的改变调解了突触损失对临床表现和行为的影响.
- 这项研究强调了在FTLD治疗开发中针对突触完整性和网络功能的重要性.
相关概念视频
Chemical Synapses
8.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Excitatory and Inhibitory Effects of Neurotransmitters
10.0K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
10.0K
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Long-term Potentiation
2.8K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.8K
Parkinson's Disease: Overview
556
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
556

